2.24
-1.75%
Close of 9 Nov 2026, in THB
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Bioscience Animal Health PCL
Its shares trade on SET under the ticker BIS.BK. It has been listed since 5 May 2022. In the fiscal year to 31 December 2025, it reported revenue of THB 2.25bn and net income of THB 38.5m. At that date it held total assets of THB 1.26bn and shareholders' equity of THB 783.0m.
Bioscience Animal Health Public Co. Ltd. engages in manufacturing, importing, and distribution of medical supplies, tools, equipment, and products for livestock and pets. The company is headquartered in Pak Kret, Nonthaburi. The company went IPO on 2022-05-05. The firm is an importer and distributor of medical supplies, tools, equipment and products for livestock and pets. The company focuses on selecting products by specialist veterinarians to improve animal health. The firm's products include antibiotic, additive, BiSMiX B-Series, BiSMiX SD Series, injection, mold inhibitor, water-soluble products, and vaccine. The antibiotic includes Omnicide FG II 1 Lit, Green Bioxide 20Liter, Salinopharm, Cevazuril, and Porcillin. The injection consists of Zuprevo, Nuflor, Ceva and Enzaprost. Its services include comprehensive farm advisor, disease prevention and surveillance program, serological examination and diagnosis program, biosafety and hygiene management program, analysis of feed raw materials, preparation of feed formulations, feed production inspection and monitoring program, management and upskilling of farm personnel.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 5 May 2022
- Website
- bis-group.com ↗
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Bioscience Animal Health PCL focuses on specialist veterinarian-selected products for animal health.
- The company distributes antibiotic products including Omnicide FG II 1 Lit and Green Bioxide 20Liter.
- Bioscience Animal Health PCL offers comprehensive farm advisor services and disease prevention programs.
Weaknesses
- The company's business is limited to livestock and pet medical supplies without expansion into other sectors.
- Bioscience Animal Health PCL has no mention of international distribution channels beyond Thailand.
- The firm relies on specific product lines like BiSMiX B-Series without diversifying its offerings.
Opportunities
- Thailand's growing livestock industry presents opportunities for Bioscience Animal Health PCL to expand its market share.
- The company can leverage its veterinary specialist network to introduce new products in the Health Care sector.
- Bioscience Animal Health PCL can enhance its services with digital farm management tools.
Threats
- Competition from other animal health suppliers in Thailand may impact Bioscience Animal Health PCL's market position.
- Regulatory changes in Thailand's Health Care sector could affect product approvals and distribution.
- Economic downturns in Thailand might reduce spending on livestock and pet medical supplies.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.